Genedrive, the Manchester-based molecular testing business which makes medical testing equipment, has received £120,000 for ...

Bristol-Myers Squibb (BMY) and Sanofi (SNY) resolve Plavix marketing litigation with Hawaii in $700M settlement. Read more ...

New findings from real-world experience support the shift in practice to single antiplatelet therapy after transcatheter ...

However, guidelines already recommend that antithrombotics after TAVR consist of lifelong SAPT (aspirin 75-100 mg daily or clopidogrel 75 mg daily) -- a strong existing class I endorsement from the ...

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, ...

Plavix (clopidogrel) can cause side effects that range from mild to serious. More common side effects include bruising, bleeding, and itching. If side effects from Plavix become difficult to ...

Although a diminished pharmacodynamic effect of clopidogrel has been demonstrated in patients treated with proton-pump inhibitors (PPIs), whether its clinical efficacy is reduced remains highly ...

South Korea: The SMART-CHOICE 3 trial demonstrated that in patients who had completed the standard course of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI), ...

The glucuronide metabolites of the antilipemic drug gemfibrozil and the antiplatelet drug clopidogrel are known as strong inhibitors of CYP2C8 leading to several DDIs. Most of the gemfibrozil dose is ...